Clinical Trial

Impact of Ziwig Endotest® on the Management of Patients With Clinical Symptoms of Endometriosis Inconsistent With Their Imaging Work-up

Study acronym: ENDOBEST
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the impact of Ziiwg Endotest on patient management decisions before and after the test. The main questions it aims to answer are: * Does the test reduce the intention and number of laparoscopies in women whose decision to undergo laparoscopy was made before the test result was obtained? * Does the test change management decisions in women with no prior indication for diagnostic laparoscopy? Study will compare the patient management decision before and after the test. The acts and procedures performed as part of this research are : * Aa saliva sampling (Ziwig Endotest) at inclusion * A mutidisciplinary meeting post test (if applicable) * Completion at inclusion and 6 month of a quality-of-life questionnaire (EHP-5) * Completion at inclusion and 6 month of a VAS for pain * Completion at inclusion and 6 month of a Likert satisfaction scale * A test results Announcement consultation * A visit at 6 months.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-20; most recent amendment 2026-03-24.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-03-24
Trial Details
NCT Number NCT06794424
Lead Sponsor ZIWIG
Collaborators: Monitoring Force Group
Conditions Endometriosis
Enrollment 2,503 participants
Start Date 2025-03-14
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-25